• Pacemakers Market Size, Share, Trends and Global Forecast 2023 - According to research report the pacemakers market is projected to reach USD 4.9 billion by 2023 from USD 4.4 billion in 2018, at a CAGR of 2.0% during the forecast period. The major driving factors in the pacemakers market are increasing prevalence of cardiovascular diseases and technological advancements in devices. The study involved 4 major activities in estimating the current market size for pacemaker. Exhaustive secondary research was done to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both the top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments. Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=243344814 The implantable pacemakers segment is projected to be the fastest-growing segment, by implantability, during the forecast period. The large share of the implantable pacemakers segment is primarily attributed to the increasing prevalence of CVDs and the rising preference for these pacemakers due to their benefits over their external counterparts. The MRI compatible pacemakers segment is projected to be the fastest-growing segment, by type, during the forecast period. This can be attributed to the growing number of patients with implanted pacemakers and the increasing need for MRI scans in the geriatric population, as patients in this age group are more likely to have cardiac devices such as pacemakers. North America is estimated to account for the largest share of the market in 2018. Factors such as the rising prevalence of CVDs, growing geriatric population, increasing healthcare expenditure, and the availability of technologically advanced devices are driving the growth of the pacemakers market in North America. The major vendors in the global pacemaker market are Medtronic (Ireland), Abbott (US), and Boston Scientific (US), BIOTRONIK (Germany), LivaNova (UK), OSCOR (US), Pacetronix (India), MEDICO (Italy), Osypka Medical (Germany), and Lepu Medical (China). Recent Developments: In November 2017, Medtronic received FDA approval and launched the Azure pacemaker with BlueSync technology in the US market In February 2017, Medtronic received CE Mark certification for its Next Generation Cardiac Resynchronization Therapy-Pacemakers In February 2017, Abbott Laboratories received FDA approval for the Assurity MRI Pacemakers In March 2016, St. Jude Medical received the CE Mark certification for MRI compatibility for its Nanostim leadless pacemakers Key questions addressed by the report: Who are the major market players in pacemakers? What are the regional growth trends and the largest revenue-generating region for pacemakers? Why are pacemaker necessary for cardiac patients? What are the major types of pacemakers? Who are the major end users of the pacemaker market? Get Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=243344814 Market Dynamics Drivers Increasing Burden of RSV Infections Growing Demand for Point-Of-Care Molecular Diagnostic Tests for the Diagnosis of RSV Infections Increasing Adoption of Molecular Diagnostics Over Immunoassays Increasing Approval of RSV Diagnostic Kits and Assays Restraint Low Detection Limits of Immunoassays Opportunities Technological Advancements in Diagnostic Methods Threats Development of RSV Vaccines Contact: Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: 1-888-600-6441 newsletter@marketsandmarkets.com  ^pop (Added: Wed Jan 02 2019 Hits: 119 Rating: 0.00 Votes: 0) Rate It

• Healthcare Biometrics Market will Grow to US$ 5.8 Billion in 2019 - Security has always remained a vital concern in healthcare sector when it comes to safeguard confidential medical data, records and patients’ privacy. Biometric devices analyze biological data of a user by capturing unique his or her physical human features and use them as a future reference (template) for user’s identification. The basic components of biometric identification systems consist of a scanning device or a reader, software to convert the scanned information into digital form and a database to store the biometric data for comparison with entered biometric data. Read Report Overview: https://www.transparencymarketresearch.com/healthcare-biometrics-market.html A variety of human features such as fingerprint, face, iris, vein, voice, hand and signature seem to reveal several potential attributes for biometric authentication. Use of biometrics with the help of these physical characteristics along with logical or physical access or both together has found a worldwide use in the healthcare sector. However, improper storage of medical data may pose a threat of invasion of the user’s identity and thus challenge patient security. Biometric solutions are facilitates the provision restricted access to rooms or computer network systems from unauthorized access. Healthcare facilities across the globe are increasingly shifting their focus on implementing biometric security solutions for patient identification and their linking to electronic health records system to the respective patients. Integrity of patient identity, efficient and safe data recording, control on medical frauds and reduction in inventory theft are some of the distinct advantages offered by biometrics. Biometrics provides healthcare professionals and patients to secure their information and keep it confidential by only being released such information to those who have the rightful access to it. Biometrics allows matching of a patient to his records with minimal possibility of errors and avoids mixing up of patient information which can have serious consequence on the health and wellbeing of such patients. Moreover, factors such as culmination of false patient identity, patient protection and reduction of the overburden of medical frauds and security of medical records have urged those in the healthcare industry to opt for biometrics. Even with the ongoing struggle in the economy, especially in the European and Asian countries, healthcare organizations are investing in biometric technologies in order to increase security, privacy and improve patient safety and thus compensate the huge amount money lost in healthcare frauds. Companies investing heavily in developing automated biometric systems with improved accuracy and response time may gain greater benefits in the near future. Introduction of new products with reduced cost and showcasing advantages and advanced capabilities of biometric security solutions at various conferences, laboratories, trade shows, web casting and electronic newsletters is further boosting the growth of new market competitors. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=615 Moreover, factors such as reduction in healthcare frauds, secured patient privacy and medical records, reduction in fake insurance claims reduction in identification and reimbursement processing, cost containment of the biometric devices and introduction of cheaper products with better accuracy will result in rapid adoption of biometrics security solutions in healthcare sector in the emerging markets. Use of multimodal biometric system, which combines different types of biometric methods, such as combining facial and iris recognition is currently rapidly progressing trend. Biometrics is a promising and a fast growing segment in the field of next generation personal authentication and security systems and is changing the perception and look of healthcare industry. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www.transparencymarketresearch.com/ (Added: Wed Jan 02 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Sports Food Market to Reach USD 102.88 billion by 2023 - Market Data Forecast - Global Sports Food Market - GSK to divest Horlicks and other Consumer Healthcare nutrition products to Unilever Recent Developments Glaxo smith is a British based pharmaceutical company. Gsk was the world’s sixth largest pharmaceutical company as of 2015. GlaxoSmithKline plc and Pfizer Inc to form new world-leading Consumer Healthcare Joint Venture. GSK acquired Tesoro, an oncology-based company to significantly strengthen GSK’s pharmaceutical business. GSK to divest Horlicks and other Consumer Healthcare nutrition products to Unilever. It presented new efficacy and safety data of an anti-GM-CSF antibody in patients with rheumatoid arthritis. To know more read: https://www.marketdataforecast.com/market-reports/sports-food-market-4213/ Market Segmentation Market Data Forecast published a report named Global Sports Food Market itis currently valued USD 66.99 billion in 2018 and it is expected to reach USD 102.88 Billion by 2023 at a CAGR of 8.32% The report is segmented by Product Type · Dietary Supplement Powder · Energy Bars · Sports Food and Drinks · Protein Bars · Sports gels Distribution Channels · Hyper marts · Supermarkets · Online Stores · Convenience Stores · Drug Stores The protein-based sports food and energy sports food have the highest share relatively compared to the other segments. Online channels have the largest share due to the rising number of Smartphone users and increasing penetration of the Internet. In gender, the male segment has been leading the global market and this trend is anticipated in the forecast period. Geographical Segmentation: Geographically, sports food market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America followed by Europe has the largest share in the Global market due to the increasing number of sports enthusiasts. Asia-Pacific is the fastest growing region due to the increasing interest of people in fitness activities, emerging economies, increasing the disposable income of people and enabling them to spend on expensive products. Key market players in the market are - Nestle Abbott Laboratories GSK Danone S.A Pepper Snapple Group View a sample and decide: https://www.marketdataforecast.com/market-reports/sports-food-market-4213/request-sample The scope of the report: The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along with this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated. The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategically activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity. What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions. Contact Info: Name: Mr. Abhishek Shukla Email: abhishek@marketdataforecast.com Organization: MarketDataForecast™ Address: 2nd Floor, Above ICICI Bank Film Nagar Branch, B 44, Rd no 3, Journalist Colony, Hyderabad, Telangana 500033, India. Phone: +1-888-702-9626 (Added: Wed Jan 02 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• 2nd International Conference on Cell and Genetherapy - Join with Featured Speakers and Experts from Europe, USA, Middle East and Asia Pacific at 2nd International Conference on Cell and Genetherapy on April 15-16, 2019 at Milan, Italy. For more details visit: http://celltherapycongress.alliedacademies.com/ (Added: Wed Jan 02 2019 Hits: 47 Rating: 0.00 Votes: 0) Rate It

• 2nd International Conference on Cell and Genetherapy - Join with Featured Speakers and Experts from Europe, USA, Middle East and Asia Pacific at 2nd International Conference on Cell and Genetherapy on April 15-16, 2019 at Milan, Italy. For more details visit: http://celltherapycongress.alliedacademies.com/ (Added: Wed Jan 02 2019 Hits: 35 Rating: 0.00 Votes: 0) Rate It

• Tympanostomy Products Market Revenues to Reach US$ 102.0 Mn by 2026 - Transparency Market Research (TMR) has published a new report titled, ‘Tympanostomy Products Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global tympanostomy products market was valued at US$ 89.0 Mn in 2017 and is projected to expand at a CAGR of 1.4% from 2018 to 2026. Otitis media is one of the most prevalent ear diseases across the globe and is most common among children. Demand for quality health care and patient safety has led to the development and introduction of new tympanostomy tubes and insertion devices. This is expected to drive adoption of the procedure across the globe. Read Report Overview: https://www.transparencymarketresearch.com/tympanostomy-products-market.html Otitis media is a condition caused by inflammatory reaction in the middle ear due to severe infections. It is one of the most prevalent ear diseases across the globe. According to the World Health Organization, around 709 million people are estimated to be affected by otitis media across the globe each year, of these around 90% are children. According to the Agency for Healthcare Research and Quality of the U.S., otitis media is the most prevalent condition among children in the U.S., with around 1 million tympanostomy tube insertion procedures performed each year in the country. Demand for quality health care and patient safety has led to development and introduction of new tympanostomy tubes and tube insertion devices. However, there are new and promising alternative treatment lines in the pipeline such as more efficient and long lasting topical antibiotics and eustachian tube balloon dilation devices. This is likely to limit adoption of tympanostomy tube insertion procedures. The report offers detailed segmentation of the global tympanostomy products market based on product, material, application, and end-user. The market has also been segmented based on region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). New tympanostomy tubes and innovative tube insertion devices are likely to drive the global market. Key players are tapping opportunities to introduce more advanced tube insertion devices with features such as one pass tube insertion and office-based procedure under conscious sedation eliminating the need for general anesthesia. Demand for tympanostomy tubes that have intermediate retention time and new coating material to avoid tissue granulation and tube blockage is likely to increase during the forecast period. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=54768 Tympanostomy procedure is performed in children under general anesthesia, which may have an impact on child’s health and growth. This has led to concerns among health care providers and parents. Key industry players and researchers such as Preceptis Medial, Inc. and researchers are the National University of Singapore have developed and introduced new tube insertion devices Hummingbird TTS and CLiKX, which perform the tympanic membrane incision and tube insertion in one pass. Moreover, tympanostomy procedure with these devices can be performed under conscious sedation in physician’s office. Furthermore, demand for patient safety and environment friendly products is driving adoption of fluoroplastic disposable tympanostomy tube insertion devices. The tympanostomy tubes segment is estimated to register modest growth during the forecast period. Easy availability, low unit price, and presence of large number of suppliers are anticipated to contribute to the modest growth of the tympanostomy tube segment. Asia Pacific is expected to present significant opportunities in the tympanostomy products market due to changing economic profiles, surge in purchasing power, high prevalence of otic diseases, and improving health care infrastructure. High unmet needs in disease therapeutics is likely to augment the tympanostomy products market in Asia Pacific. In terms of revenue, North America was the leading market for tympanostomy products in 2017. The market in North America is anticipated to witness moderate growth during the forecast period. Presence of key players, high adoption for technically advanced tympanostomy tubes and tube insertion devices, and higher product prices contributed to the region’s high share of the global market. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=54768 The global tympanostomy products market is dominated by five key players operating internationally. However, the regional markets are highly fragmented, with large number of small and medium scale manufacturers. Olympus Corporation, Medtronic plc, Atos Medical, Grace Medical, and Summit Medical are the five key players operating in the global market. These players have broad portfolio of tympanostomy tubes and tube insertion devices of different shapes, sizes, and materials. Moreover, these players offer supportive or ancillary otorhinology products such as middle ear prostheses, stapedectomy procedure devices, and otology endoscopes and endoscopic instruments, which augment their market presence. Product differentiation is another key strategy adopted by players. Grace Medical uses its proprietary cold molding technology for tympanostomy tube manufacturing. Preceptis Medical has industry leading one pass tube insertion devices. Major companies profiled in the report are Olympus Corporation, Medtronic plc, Summit Medical, Inc., Grace Medical, Atos Medical, Preceptis Medical, Inc. OtoMedics Advanced Medical Technologies Ltd., EON Meditech Pvt. Ltd., and Koken Co., Ltd. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www.transparencymarketresearch.com/ (Added: Wed Jan 02 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Angio Suites Market Segments, Opportunity, Growth and Forecast By End-use Industry 2018-2028 - Siemens leads the packs globally, FMI offers an extensive assessment of the competitive landscape of angio suites market for 2018-2028 With an estimated incremental opportunity of more than US$ 100 million over 2018, the global revenue through sales of angio suites is likely to approach US$ 1.9 Bn in 2019. As reported by a new research intelligence study on the global angio suites market, there will be more than 6% year on year revenue growth in 2019 – reflecting a healthy outlook for the angio suites landscape at a global level. Key Research Insights Drawn from the Report In a consolidated market structure, the top three companies operating in the global angio suites landscape hold a whopping revenue share of around 70%. Easy, fast-track FDA clearance holds vital importance in shaping the new product developments and launches. Innovative therapy suites and angio suites are receiving wider platforms in recent years, with growing government funds and consistently increasing voluntary funds - pushing R&D activities further. Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7758 More than 1/4th Share of the Market Revenue Belongs to Siemens Siemens AG, reportedly the global leader in angio suites landscape, has been highly active in terms of innovation in recent years. The company had announced the launch of two products adding value to its innovative offerings in Nov 2017. Siemens Healthineers unveiled two imaging therapy suites that are intraoperative and possess multi-modality imaging capability. While interventional surgeons and radiologists are continuously striving to discover novel procedures that are highly precise yet rapid and affordable, Siemens’ Angio-MR-CT and Angio-CT therapy suites have been presented as a breakthrough innovative solution. Later the same year, the company entered a 10-year contractual partnership with Kingston Hospital NHS Foundation Trust over the supply of all-inclusive Managed Equipment Services (MES) to the trust for a wide range of medical imaging systems. The other two market leaders include Philips Healthcare and GE Healthcare LLC, which are prominently concentrating on innovative product launches for global expansion and introduction of disruptive technology based systems across developing regional markets. Explaining the most popular developmental strategies adopted by key companies in angio suites landscape, the FMI analyst says, “The strategic focus of angio suites market players is likely to remain on vertical and horizontal integration. Our research concludes that direct selling strategy is allowing companies to cater to the escalating demand for technically innovated products”. Discussing further about the growing significance of having a strong distribution network, “Key players are also prioritizing a stronger distribution network at a global level. Whereas, development of independent distribution channels for personal selling of angio suites is also identified to be one of the key trends among market players,” says the analyst. Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-7758 Segmental Analysis: Single Plane Angio Suites and Hospitals Remain Top Performing Segments With more than 65% share of the global market revenue, single plane angio suites continue to dominate biplane angio suites, according to the report. Although cath labs are likely to demonstrate impressive adoption of angio suites in the near future, hospitals remain the largest end user of angio suites. Currently, Asia Pacific accounts for over 45% share of the total market revenue, followed by Europe that holds around 30% share in the market value. The report projects emergence of lucrative business opportunities in developing regional markets, besides APAC, i.e. MEA and Latin America. While the opportunity assessment of emerging regional markets for angio suites analyses the sales force expansion and third party payer coverage in the regions, remarkable reimbursement support and improving customer care are identified to be the primary factors boosting revenue growth of angio suites market in these regions. In a bid to achieve high operational efficiency, a number of companies are strategizing the shifting of their manufacturing facilities to low-cost production bases in emerging economies of Latin America and APAC. (Added: Wed Jan 02 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• 4th International Conference On Gastroenterology and Endoscopy (Added: Wed Jan 02 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Infectious Disease Therapeutics Market is poised to touch USD 154.18 Billion by 2023 - Infectious Disease Therapeutics Market– GlaxoSmithKline plc (GSK) had introduced a new drug. Recent Developments GlaxoSmithKline plc (GSK) had 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines, and consumer healthcare products. GlaxoSmithKline (GSK) and Isis Pharmaceuticals Inc. had announced a new strategic alliance that will apply the Isis antisense drug discovery platform to seek out and develop new infectious disease therapeutics product against targets for rare and serious diseases. To know more read: https://www.marketdataforecast.com/market-reports/infectious-Disease-therapeutics-market-1320/ Market Segmentation Infectious Disease Therapeutics Market worth was USD 105.13 Billion in 2018 and estimated to reach USD 154.18 Billion by the end of 2023 with a growing potential of 7.96 %. Report is segmented by Target Organism Antibacterial Antifungal Antiviral Antiparasite Infection type Bacterial Viral Fungal parasitic Increase in the geriatric population and increasing healthcare expenditure are some of the key factors driving the growth for the global infectious diseases therapeutics market. Rising healthcare awareness is also fuelling the growth of the global infectious diseases therapeutics market. Geographical Segmentation: North America is expected to account the majority share in the market followed by Asia-Pacific and Europe owing to a rising incidence of infectious diseases, and increasing the aging population. Asia-Pacific is projected to account for the highest CAGR over the forecast period owing to increasing government funding in some emerging countries such as India, China. Key market players in the market are - Hoffmann-La Roche Gilead Sciences GlaxoSmithKline Johnson & Johnson View sample and decide:https://www.marketdataforecast.com/market-reports/infectious-Disease-therapeutics-market-1320/request-sample The scope of the report: The report gives a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along with this, the factors influential in effecting the current market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is measured and the prospects with high growth potential are identified and debated. The major players in the industry are profiled providing insights on their financial performance, market position, and the growth strategies. Comparative analysis on key strategically activities of the market players delineating the key developments like mergers and acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also provides a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity. What else? Apart from the syndicated report, our in-house team has expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions. Contact Info: Name: Mr. Abhishek Shukla Email: abhishek@marketdataforecast.com Organization: MarketDataForecast™ Address: 2nd Floor, Above ICICI Bank Film Nagar Branch, B 44, Rd no 3, Journalist Colony, Hyderabad, Telangana 500033, India. Phone: +1-888-702-9626 (Added: Wed Jan 02 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Endoscopy Visualization System Market Value Share, Supply Demand - Around 3/4th share of the total revenue of endoscopy visualization systems landscape is accounted by Tier 1 players that are prominently focusing on cost effective product development Leaders in endoscopy visualization systems landscape are also prioritizing innovative product launches, product portfolio extension, and strategic collaborations and mergers for an even stronger market footprint. Tier 2 and Tier 3 companies, making up for the rest of market revenue, are particularly focusing on regional expansion – especially targeting developing Asian economies. Prominently due to the paradigm shift to value based, sophisticated healthcare system and a mounting number of strategic mergers and acquisitions between leading medical device manufacturers, endoscopy visualization systems have been witnessing robust demand in recent years. “With an ever growing demand for minimally invasive surgical procedures and growing availability of low-cost diagnostic procedures, we expect robust expansion of the global revenue through endoscopy visualization systems. While endoscopy visualization systems currently account for a billion dollar market globally, it is more likely that the endoscopy visualization systems landscape will observe over 7% year on year growth in 2019. Relatively undemanding FDA clearance guidelines is another strong factor pushing the prospects for endoscopy visualization systems in the near future,” says a senior research analyst at Future Market Insights. Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7596 Innovation of Endoscopy Visualization Systems Takes a Grand Leap beyond 3D Imaging The 3D endoscope visualization system has been an impactful innovation in the endoscope visualization systems landscape. While 3D visualization technology offers a deeper view of the diagnostic area during endoscopic procedures, constant R&D efforts have directed the innovations to the latest - customized 3D visualization. The world's first-ever endoscopy visualization system (by MedicalTek) has been recently launched that works on an easy-to-set and easy-to-alter imaging technique and offers an adjustable 3D perception to resultant endoscopic images. Product Type Assessment: Adapting to the Trend of Minimally Invasive Surgery Demand, High-range Endoscopy Visualization Systems Remain the Top Seller The FMI analyst explains that ever-growing demand for minimally invasive surgical procedures worldwide, it is quite clear that high-range endoscopy visualization systems will continue to bring in maximum revenue to the marketplace. With a current market value share of around 50%, high-range endoscopy visualization systems will be the highest selling type of EVS owing to favorable reimbursement policies and availability of advanced technology systems in this segment. Mid-range endoscopy visualization systems are also identified to capture a considerable market value share in 2019, demonstrating the year-on-year expansion of over 7%. Diagnostic Area-wise Analysis: Maximum Opportunities Exist for GI Tract Endoscopy Visualization Systems Recent statistical data published by American Society of Gastrointestinal Endoscopy (ASGE) indicates that among roughly 75 million endoscopic procedures annually performed at a global level, more than 65% are performed on the gastrointestinal tract, followed by the female reproductive tract. A considerable number of endoscopies are also performed through a small-sized incision with an objective to achieve least invasion. According to FMI’s projection for 2019, the year on year revenue growth will be around 7% in case of gastrointestinal tract endoscopy visualization systems, whereas that in case of small-sized incision procedures will be more than 7%. Regional Outlook: Asia Pacific Becomes an Attractive Growth Platform for Manufacturers of Endoscopy Visualization Systems While developing economies are constructing a lucrative base for the growth of endoscopy visualization systems landscape through changing demographics and an expanding patient pool, Future Market Insights offers exclusive insights on the same. An elevating number of endoscopy visualization systems predominantly for disorders of GI tract, female reproductive system, urinary tract, and respiratory system is encouraging the sales of endoscopy visualization systems in emerging Asian economies. Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-7596 The FMI analyst says while unfolding the key attributes driving expansion of market within emerging regional territories, “While APEJ is at present the second largest market for endoscopy visualization systems after North America, Japan is also witnessing significant growth. This growth can be attributed to both, a healthy rate adoption of endoscopy visualization systems at hospitals, and impressively growing sales at specialty clinics”. (Added: Wed Jan 02 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Nextt: Offering Safe & Secure Disability Housing In Australia - One of Australia's leading provider of personalised care, high-value and support services, Nextt works with you so you can get more out of life. Our programs and supports for people with autism, cognitive disabilities, mental health and dementia are highly useful. Our reliable team of carers provides comprehensive disability services in NSW, Victoria, Queensland and South Australia. We provide skill building, in-home support, nursing, specialist housing and community services to individuals at all stages of life, from infants through to older Australians, and to individuals with a wide range of physical and cognitive abilities. Nextt provides disability support for an independent lifestyle and a life of your choice. Our team believes that the support provided must focus on tailored skill development to enhance independence. We work with the NDIS, local government & other partners to make it happen. Our professionals work tirelessly to deliver highly personalized care that suits the individual and their own needs in life. Our dedicated team help you to provide Disability Housing Australia, where you or your loved one can live peacefully and comfortably. We have delivered community care, support and services since 2003, initially delivered through a wide range of government-funded programs, and now including a wide range of privately-funded choices. We are continuously on the look out for properties that can cater specifically for our clients. Our specialist properties cater to all care needs, across transition, cluster homes or supported housing. Our friendly staff can assist you to: build your independence within your home, participate and connect with others within your community, explore opportunities for learning and development, including employment support, creating goals, develop independent living skills that can be connected to living environments and in difficult situations, actively participate in the development of your individual plan to build skills and manage your own needs. We provide support during all areas of life, including: self care, daily living skills, home and financial management, education support, employment support, social and spiritual events, activities and groups. The choices, preferences, aspirations, life goals and overall quality of life of the individual are central to the support and services we give, across all our areas of expertise. Our front-line client-facing staff are amongst a superb and supportive team who provide the best service possible for our clients. About the Company: Nextt, a leading provider of Disability housing in Australia for individuals who have autism, a disability or face mental health challenges where they can be enabled to develop independence while living a meaningful life. Our team understands our obligations to our clients and meet them with dedication and professionalism. Contact details: Address: Nextt Group 4 Darley Street Darlinghurst NSW 2010 Phone Number: 1300 859 199 (02) 8736 7200 Website: https://www.nextt.com.au/ (Added: Wed Jan 02 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Cardiac Ultrasound Systems Market Analysis, Overview - Accounting for around 31% deaths that occur globally each year, cardiovascular disorders are the key cause of over 17 million deaths across the world – says WHO. With constantly increasing number of referrals to cardiologists and technological advances driving innovation in the existing cardiac imaging devices, the global cardiac ultrasound systems landscape is slated for positive growth prospects in the near future. According to a recently released intelligence study by Future Market Insights, the current valuation of cardiac ultrasound systems market is over a billion dollar and is likely to expand at a promising rate over the next two years. The top three companies operating in the global competitive landscape are holding over 45% share of the current market revenue, whereas an equal portion of the market value is being contributed collectively by relatively smaller players. A majority of them are focusing on strategic mergers, acquisitions, and collaborations for expanded product portfolio. Growing concentration on firming up across the value chain is a recent trend observed among companies, according to FMI research. “This trend will particularly accelerate the forward integration of cardiac ultrasound systems landscape. Moreover, enhanced efforts for a stronger distribution network in emerging economies also highlights the current strategic scene of the global cardiac ultrasound systems landscape,” says a senior research analyst at FMI. Explaining further about the competition scenario, the analyst says, “As a continued effort to attain higher RoI, companies are shifting their manufacturing bases to low-cost production bases, i.e. developing countries”. FMI’s cardiac ultrasound systems market report evaluates the key trends influencing the product performance. Compact, attractively designed, and user-friendly cardiac ultrasound systems are available online, creating more revenue generation channels. Portable cardiac ultrasound systems are witnessing remarkable market penetration in recent years. A dramatically growing number of specializations in imaging technology and the rising number of independent imaging centers is providing a strong impetus to revenue growth. Growing use of bedside ultrasonography is likely to push the prospects for portable cardiac ultrasound systems. Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7692 Limitations Posed by High Price Point Are Still Prevalent While the healthcare industry is continuously striving for a better reimbursement scenario, the high price point still remains a significant limiting factor impacting the sales of cardiac ultrasound systems – especially in developing economies. Even the largest end users of cardiac ultrasound systems, i.e. hospitals, clinics, and diagnostic and imaging centers are still reluctant to an extent, about installation of new cardiac ultrasound systems – which is primarily attributed to the lack of adequate grants from governments for the substantial capital investment. On the other side, the market landscape remains consolidated, leading to a high pricing premium and thus the limited availability of cardiac ultrasound systems. Mobile Connectivity Is Rapidly Invading End User Preferences for Medical Devices FMI through extensive research senses a strong possibility of the newly introduced handheld wireless cardiac ultrasound systems gradually replacing conventional devices in the near future. Such a system offers a dual advantage, compact portability and connectivity with personal mobile devices. Growing patient preference for connected ultrasound systems for real-time visualization and diagnosis marks a recent milestone shaping the performance of cardiac ultrasound systems landscape. Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-7692 North America Reigns Supreme in Global Landscape, MEA is Witnessing Promising Sales of Cardiac Ultrasound Systems More than 610,000 deaths due to CVDs are registered in the US alone, whereas over 735,000 citizens in the country suffer from a heart attack, each year – says the Center for Disease Control & Prevention. As a result, with more than 1/3rd share of the total market revenue, North America is dominating other regional markets for cardiac ultrasound systems. In addition to favorable reimbursement policies of the US Government, escalating demand for 3D cardiac ultrasound systems is pushing the growth of North America’s marketplace. Strong key player presence, early technology adoption, and better pricing scenario collectively continue to raise the overall attractiveness of the region as a top performing cardiac ultrasound systems market. Among developing economies, China, India, and gulf economies in the MEA region are offering promising signs of growing cardiac ultrasound system sales. Rapid sophistication of the healthcare and medical sector in gulf economies is identified to be the key factor driving growth of MEA market. (Added: Tue Jan 01 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Rare Hematology Market to Rise at 6.2% of CAGR Between 2017-2022 - The global rare hematology market is expected to witness a healthy growth attributed to growing prevalence of blood related disorders. Surge in demand to conduct the diagnosis process at the early phase is expected to impact growth of the global rare hematology market significantly. Moreover, increasing number of clinical trials to develop enhanced treatment process is further expected to encourage the progress of the global rare hematology market. With the growing demand for shorter diagnosis procedure, hematologists are increasingly focusing on enhancing their diagnosis skills. Read Report Overview: https://www.transparencymarketresearch.com/rare-hematology-market.html The report offers an in-depth insight on some crucial aspects of the global rare hematology market and provides information on the growth patterns, factors fuelling the market growth, competitive landscape and important segments. Growth of the global rare hematology market is mainly bound by various macro-economic and micro-economic factors. The report reveals that the global rare hematology market is mainly driven by the growing prevalence of various blood related disorders. As majority of the treatment procedures for the hematology diseases are not certified by the FDA, the hematologists are increasingly focusing on development new and safe drug products for enhanced treatment procedure. As hundreds of the clinical trials that are at the final stage are mainly stuck in the FDA pipeline for approval and evaluation, the global rare hematology market is expected to witness an inhibiting growth. Moreover, the researchers, patients, advocacy groups and caregivers are uniting to spread awareness about the blood disorders. On the other hand, inadequate support by the disease-specific foundations for research is expected to restrain growth of the global rare hematology market. Moreover, the patients, advocacy groups, caregivers and patients are coming together in order to spread awareness. These factors are likely to contribute towards growth of the global market. The global rare hematology market is mainly segmented into treatment type, age and region. On the basis of treatment type, the global market is segmented as plasma derived factors, recombinant factors, hemophilia A, hemophilia B, von wilebrand disease, acquired hemophilia A and others. Based on age, the global market is segmented as adult and pediatric. By regions, the global rare hematology market is segmented as North America, Latin America, Europe, Japan, APEJ and MEA. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=34736 Key players operating in the global market of rare hematology are Bayer Healthcare AG, Pfizer Inc., PRA Health Sciences, Alexion Pharmaceuticals, Inc., Shire plc, Pfizer Inc., Celgene Corporation, Amgen Inc., Biogen Inc., Novo Nordisk A/S, CSL Behring LLC and PRA Health Sciences. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www.transparencymarketresearch.com/ (Added: Tue Jan 01 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• 49th World Congress on Advanced Nursing Research - We are taking the opportunity by inviting you all and welcome to join our 49th World Congress on Advanced Nursing Research during June 10-11, 2019 at Berlin, Germany with a theme “Focusing on Novel Strategies in Nursing Research” Nursing Research 2019 will focus on educational advanced nursing research directed towards its impact on clinical practice and outcomes, through oral and poster presentations, educational workshop sessions, and influential plenary presentations. Attendees will be provided with the tools to enhance nursing research education programs to make education more effective in nursing practice. The Nursing Research Conferences is a platform for nursing students, faculty, deans, researchers, and leaders to collaborate on topics affecting nursing education. Conference website: https://nursingresearch.nursingmeetings.com/ Who can attend? Nursing Research Conferences brings together individuals who have an interest in different fields of nursing like psychiatric, cancer, cardiac, critical care, adult & women health, legal, pediatric and emergency nursing, midwifery, public health, healthcare and medicine from practice, research, administration, corporate executives, policy and education. It is a forum to explore issues of mutual concern as well as exchange knowledge, increased visibility of nursing research, share evidence, ideas, and generate solutions. Why to Attend??? Advanced Nursing Research 2019 provides a global platform for exchanging ideas and makes us updated about the latest innovations in advanced nursing research and healthcare. Opportunity to attend the presentations delivered by Eminent Scientists from all over the world Contact: Rachel Jacob Program Director | Nursing Research 2019 Email: nursingresearch@annualconferences.org (Added: Tue Jan 01 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• 49th World Congress on Advanced Nursing Research - We are taking the opportunity by inviting you all and welcome to join our 49th World Congress on Advanced Nursing Research during June 10-11, 2019 at Berlin, Germany with a theme “Focusing on Novel Strategies in Nursing Research” Nursing Research 2019 will focus on educational advanced nursing research directed towards its impact on clinical practice and outcomes, through oral and poster presentations, educational workshop sessions, and influential plenary presentations. Attendees will be provided with the tools to enhance nursing research education programs to make education more effective in nursing practice. The Nursing Research Conferences is a platform for nursing students, faculty, deans, researchers, and leaders to collaborate on topics affecting nursing education. Conference website: https://nursingresearch.nursingmeetings.com/ Who can attend? Nursing Research Conferences brings together individuals who have an interest in different fields of nursing like psychiatric, cancer, cardiac, critical care, adult & women health, legal, pediatric and emergency nursing, midwifery, public health, healthcare and medicine from practice, research, administration, corporate executives, policy and education. It is a forum to explore issues of mutual concern as well as exchange knowledge, increased visibility of nursing research, share evidence, ideas, and generate solutions. Why to Attend??? Advanced Nursing Research 2019 provides a global platform for exchanging ideas and makes us updated about the latest innovations in advanced nursing research and healthcare. Opportunity to attend the presentations delivered by Eminent Scientists from all over the world Contact: Rachel Jacob Program Director | Nursing Research 2019 Email: nursingresearch@annualconferences.org (Added: Tue Jan 01 2019 Hits: 4 Rating: 0.00 Votes: 0) Rate It

• 49th World Congress on Advanced Nursing Research - We are taking the opportunity by inviting you all and welcome to join our 49th World Congress on Advanced Nursing Research during June 10-11, 2019 at Berlin, Germany with a theme “Focusing on Novel Strategies in Nursing Research” Nursing Research 2019 will focus on educational advanced nursing research directed towards its impact on clinical practice and outcomes, through oral and poster presentations, educational workshop sessions, and influential plenary presentations. Attendees will be provided with the tools to enhance nursing research education programs to make education more effective in nursing practice. The Nursing Research Conferences is a platform for nursing students, faculty, deans, researchers, and leaders to collaborate on topics affecting nursing education. Conference website: https://nursingresearch.nursingmeetings.com/ Who can attend? Nursing Research Conferences brings together individuals who have an interest in different fields of nursing like psychiatric, cancer, cardiac, critical care, adult & women health, legal, pediatric and emergency nursing, midwifery, public health, healthcare and medicine from practice, research, administration, corporate executives, policy and education. It is a forum to explore issues of mutual concern as well as exchange knowledge, increased visibility of nursing research, share evidence, ideas, and generate solutions. Why to Attend??? Advanced Nursing Research 2019 provides a global platform for exchanging ideas and makes us updated about the latest innovations in advanced nursing research and healthcare. Opportunity to attend the presentations delivered by Eminent Scientists from all over the world Contact: Rachel Jacob Program Director | Nursing Research 2019 Email: nursingresearch@annualconferences.org (Added: Tue Jan 01 2019 Hits: 5 Rating: 0.00 Votes: 0) Rate It

• Neuroendocrine Carcinoma Market Poised To Register Healthy Expansion in Upcoming Years - A neuroendocrine tumor is a kind of tumor that begins in the hormone producing cells of the neuroendocrine system that is made up of the endocrine system and nervous system. Hormones producing neuroendocrine cells have a structure similar to neurons and produce hormones like endocrine cells. These cells are found throughout the body in organs such as intestines, kidneys, lungs and stomach and perform functions such as controlling the speed of food through gastrointestinal tract and air and blood flow through the lungs. Neuroendocrine tumor is a rare malignant disorder that accounts for nearly one percent of all malignant disorders. Neuroendocrine carcinomas account for nearly 60% of all neuroendocrine tumor cases and are characterized as their origin in different locations throughout the body including lungs, gastrointestinal tract and brain. Some common symptoms associated with neuroendocrine carcinoma are hyperglycemia, hypoglycemia, weight loss, loss of appetite, headache, anxiety, gastric ulcer, unusual bleeding, jaundice, diarrhea, fever and persistent in specific area. Read Report Overview: https://www.transparencymarketresearch.com/neuroendocrine-carcinoma-market.html The treatment options for neuroendocrine carcinoma include surgery, radiation therapy and chemotherapy. Chemotherapy involves the use of drugs to kill cancerous cells by inhibiting the cells ability to grow and divide. Streptozocin (Zanosar) and 5-fluorouracil (Adrucil, 5-FU) are some drugs that are used to treat neuroendocrine carcinomas. Continuous efforts by major pharmaceuticals in order to develop targeted therapy have been contributing in the growth of neuroendocrine carcinomas market. Everolimus (Afinitor) and sunitinib (Sutent) are two major targeted drugs that are being used for treating neuroendocrine carcinomas. Afinitor was introduced by Novartis AG in 2009 for the treatment of advanced renal cell carcinoma. This drug is useful when sunitinib or sorafenib fail to treat the renal cell carcinoma. Sutent is a brand developed by Pfizer Ltd. and is used to treat advanced renal cell carcinoma and gastrointestinal stromal tumor. F. Hoffmann-La Roche Ltd., BioSynthema, Inc., Genentech Inc. and Callisto Pharmaceuticals Pvt. Ltd. are some major companies that are striving to develop drugs for treating various neuroendocrine carcinomas. Avastin, Atiprimod and Lutathera are among other molecules that are currently being studied for their therapeutic efficacy in the treatment of neuroendocrine carcinomas. Geographically, the market for neuroendocrine carcinoma has been segmented into North America, Europe, Asia Pacific and Rest of the World (RoW). United States and Canada are the two major markets in North America region. North America represented the largest market for neuroendocrine carcinoma in 2013, with a largest market share in terms of revenue (USD Million). According to sources from Cancer.Net, nearly 8,000 people are diagnosed with neuroendocrine tumors every year in the United States. Many of the key players operating in this market space are based out of U.S and thus consider North America as their primary market for product launch and investment. Also, the well established healthcare infrastructure and reimbursement scenario are among the major factors responsible for North America’s leading position in neuroendocrine carcinoma market. Europe accounted for the second largest market in 2013, followed by Asia Pacific and Rest of the World (RoW). Growing incidence of neuroendocrine carcinoma in Asia Pacific along with the improving economic scenario is likely to play a key role in driving the market growth in the region. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2970 F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Ltd., Eli Lilly & Company, Amgen, Inc., Ispen SA, Callisto Pharmaceuticals Pvt. Ltd., Bristol-Myers Squibb, Teva Pharmaceuticals, Ltd. and Biosynthema, Inc. are among others operating in the Neuroendocrine carcinoma market. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www.transparencymarketresearch.com/ (Added: Tue Jan 01 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Drug Eluting Balloon Market: Rise in Coronary Artery Diseases to Drive the Market - Drug eluting balloon is a semi-compliant angioplasty balloon, coated with anti-proliferative medicine. The medicine is ejected to the vessel walls during the inflation of the balloon. The balloons are inflated through application of nominal pressure. The active substance of the balloon is highly lipophilic in nature. Drug eluting balloon homogeneously delivers the drug to the vessel and prevents neointimal hyperplasia (proliferation of vascular smooth muscle and thickening of arterial wall, thus reducing the arterial lumen space). The device has gained popularity as it helps in effective treatment of in-stent restenosis as compared to drug eluting stent or bare metal stent. Rise in peripheral and coronary artery diseases among the geriatric population is likely to drive the global drug eluting balloon market in the near future. Read Report Overview: https://www.transparencymarketresearch.com/drug-eluting-balloons-market.html The global drug eluting balloon market is characterized by increase in incidence of peripheral artery diseases (PAD) across the world. The market is witnessing gradual rise in research and development activities supported by government policies. The global drug eluting balloon market was valued at US$ 420 Mn in 2017 and is projected to reach US$ 1800 Mn in 2026, expanding at a CAGR of 18% from 2018 to 2026. Growth in geriatric population, which is prone to cardiovascular diseases, large patient base in developing countries demanding proper treatment, and investments made by public and private market players in R&D on drug eluting balloon for treatment of peripheral and coronary artery diseases are the major factors driving the global drug eluting balloon market. However, lengthy regulatory approval procedure, significant investment required due to high attrition rate in clinical trials, and adverse effects such as coronary artery lesion and lumen enlargement are likely to restrain the growth of the global drug eluting balloon market during the forecast period. Drug eluting balloon are gaining popularity among surgeons as they have proved effective in the treatment of peripheral artery and coronary artery diseases. Use of drug eluting balloon reduces the risk of stent failure and are found to be more effective in the treatment of superficial femoral artery (SFA) lesions than drug eluting stents or bare metal stents. Investment in R&D for drug eluting balloon and partnerships for co-development and commercialization of anti-infective agents are expected to fuel the growth of the global drug eluting balloon market in the near future. In terms of product, the global drug eluting balloon market has been classified into coronary drug eluting balloon, peripheral drug eluting balloon, and others. The others segment comprises drug eluting balloon used in the renal and urology field. The peripheral drug eluting balloon segment is projected to dominate the market during the forecast period. Growth of the segment can be attributed to the increasing use of drug eluting balloon in the treatment of peripheral artery diseases as these devices are easy to use and the treatment shows improved patency rate as compared to that of standard PTA balloons. Moreover, presence of key companies, such as, Medtronic and Boston Scientific Corporation engaged in manufacturing and research & development of drug eluting balloon is boosting the growth of the peripheral drug eluting balloon market. Furthermore, initiatives taken by public and private organizations are aimed toward developing new drug eluting balloon for treatment of different medical conditions. The relatively stable growth rate of the segment can be ascribed to the increase in antibiotic resistance of bacteria and limited pipeline drug candidates. The coronary drug eluting balloon segment is anticipated to register an above average growth rate during the forecast period despite the predominant use of drug eluting stents in coronary interventions. Rise in preference for drug eluting balloon for coronary interventions has been observed among physicians as these devices have the potential to eradicate the risk of stent failure and show higher efficiency than drug eluting stents. Additionally, anticipated product launches by Boston Scientific and Concept, Medical, Inc. are likely to drive the coronary drug eluting balloon segment during the forecast period. Based on drug coating technology, the drug eluting balloon market has been divided into Paccocath, FreePac,TransPax, EnduraCoat, and others. The FreePac segment is likely to dominate the market during the forecast period with an average growth rate, followed by the others segment, due to entry of several new drug coating technologies in the market. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2321 Based on end-user, the global drug eluting balloon market has been segmented into hospitals and ambulatory surgical centers, CATH labs, and others. Hospitals and ambulatory surgical centers is expected to propel the global drug eluting balloon market during the forecast period. In terms of region, the global drug eluting balloon market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a major share of 42% of the global drug eluting balloon market in 2017. Europe was another major market for drug eluting drugs in 2017. Developed health care infrastructure and relatively high paying capacity of patients of North America and Europe compared to that in emerging countries provide assured investment return to new market entrants, which has contributed significantly to the market share of these two regions. High growth rate of the pharmaceutical industry in India and China and investment made by global companies in China for development of novel treatment approaches for cardiovascular disease are expected to propel the drug eluting balloon market in Asia Pacific. Major players operating in the global drug eluting balloon market include Medtronic, Becton, Dickinson and Company (BD), Boston Scientific Corporation, Cook Medical, B. Braun Melsungen AG, Koninklijke Philips N.V., Opto Circuits (India) Limited, Terumo Corporation, Surmodics, Inc, and Biotronik. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www.transparencymarketresearch.com/ (Added: Tue Jan 01 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Men’s Health Therapeutics Market Outlook to 2024 Reported in Latest Research - The rising psychological, economic, biological, and social factors affecting men’s health are slated to propel the global men’s health therapeutics market. Research conducted by the World Health Organization (WHO) shows that life expectancy at birth for males was 69.1 years, while that for women was 73.8 years. Thus, it was found that women live longer than men on a global scale in a study conducted in 2015. Read Report Overview: https://www.transparencymarketresearch.com/mens-health-therapeutics.html The report conveys key information related to the recent market developments, opportunities, trends, growth drivers, and restraints of the global men’s health therapeutics market. The business strategies, product portfolios, and market shares held by the major players are discussed in detail. The market attractiveness, Porter’s five force analysis, market forecasts, value chain analysis, the past, present, and projected leading segments of the global men’s health therapeutics market are also presented in the report. Changing lifestyles, indulgence in risky activities, usage of illegal drugs, consumption of liquor, and smoking have been causing several disorders and health conditions among men. Work-related problems such as stress and anxiety have also been contributing to the prevalence of health conditions, fuelling the demand for these therapeutics. Moreover, studies have found that cancer prevalence among males is more than that among females. The widespread popularity of convenience food, junk food, and other unhealthy eating habits have further augmented the incidence of men’s health issues. The rising health awareness among people, increasing disposable incomes, and large healthcare expenditures are also driving the growth of this market. On the other hand, hesitation of seeking medical advice might restrict the growth of the market due to factors such as social taboos and negative self-perception. However, a gradual shift in attitudes about men’s health are likely to aid in the expansion of the market as several healthcare providers, physicians, and medical organizations are ensuring that men feel more comfortable when seeking medical assistance. Moreover, the development of numerous pipeline drugs for the treatment of men’s health issues are likely to present significant opportunities for the global men’s health therapeutics market. The global men’s therapeutics market can be segmented to include categories such as male hypogonadism therapy, prostate cancer therapy, erectile dysfunction therapy, and premature ejaculation therapy. On the basis of geography, the global men’s health therapeutics market can be segmented into Asia Pacific, North America, Europe, and Rest of the World. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1974 The region of North America is projected to contribute to market expansion to a significant extent due to aging baby boomer population and sedentary lifestyles. Increased incidence of diseases caused by smoking such as emphysema, chronic obstructive pulmonary disease (COPD), and lung cancer among the western population are slated to drive the demand for these therapies in Europe and North America. The American Lung Association found that increasing number of men are diagnosed with lung cancer every year. Compared to other ethnic groups, the African-American men are at a higher risk of dying from this disease, finds the study. Some of the major companies operating in the global men’s health therapeutics market are Access Pharmaceuticals, Inc., Intas Pharmaceuticals Ltd., ASKA Pharmaceutical Co., CordexPharma, Inc., Trophogen, Inc., ZydusCadila Healthcare Ltd., and Pantarhei Bioscience BV. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www.transparencymarketresearch.com/ (Added: Tue Jan 01 2019 Hits: 4 Rating: 0.00 Votes: 0) Rate It

• Anticoagulant Drugs Market Trends & Forecast to 2025 - Antithrombotic is a drug that helps prevent the formation of thrombus or clot. Antithrombotic and anticoagulant agents are drugs used to reduce the formation of blood clots by reducing the body’s capability to form a blood clot. These drugs act by preventing the production of vitamin K in the liver. Antiplatelet, anticoagulant, and thrombolytic agents are different types of antithrombotic agents that act through different clotting processes. Arterial and venous thrombosis, the two types of thrombosis, can be treated with antithrombotic drugs. Read Report Overview: https://www.transparencymarketresearch.com/antithrombotic-drugs-market.html The three key causes of thrombosis are hypercoagulability, abnormal flow of blood, and injury caused to endothelial cells of the blood vessel wall. These causes result from genetic conditions, inactivity, smoking, blood vessel damage, pregnancy, and obesity. Currently, thrombosis and associated disorders including myocardial infarction, stroke, and pulmonary embolism are primarily treated with off-patent anticoagulant drugs viz. warfarin and heparin. The other form of antithrombotic drugs i.e. aspirin is also off-patent. With a few patented effective cures available in the market, pharmaceutical companies have ample opportunities to innovate new products. The new drugs could be profitable for them, as the burgeoning world population would ensure steady increase in the demand for such life-saving drugs. The global antithrombotic/anticoagulant drugs market is expected to witness high growth during the forecast period, owing to factors such as high availability of these drugs and chronic conditions associated with thrombosis that require long-term drug administration. The antithrombotic/anticoagulant drugs market has been segmented by drug class, application, route of administration, and end-user. Based on drug class, the global antithrombotic/anticoagulant drugs market has been segmented into coumarins & indandiones, factor Xa inhibitors, heparins, and thrombin inhibitors. Based on application, the market can be segmented into atrial fibrillation, deep vein thrombosis, artificial heart valve, pulmonary embolism, prevention of blood clots (for example, genetic clotting disorders, stroke, and trauma), and heart attack. All over the world, more than 10 million deaths are caused by arterial thrombotic events every year. Rising prevalence of cardiovascular diseases and accidental injuries is a key factor expected to boost the antithrombotic/anticoagulant market during the forecast period. Based on route of administration, the global antithrombotic/anticoagulant drugs market has been segmented into oral route and parenteral route. The parenteral route segment is expected to witness high growth during the forecast period, owing to rapid onset of action shown by parenteral drugs. By end-user, the market has been segmented into hospitals, specialty clinics, and ambulatory surgical centers. Among these, the hospitals segment accounted for a major market share in 2016, while the specialty clinics segment is expected to witness high growth during the forecast period. The global market for antithrombotic/anticoagulant drugs is also driven by some other factors such as lack of specific substitutes for antithrombotic and anticoagulant drugs, rising geriatric population, rising prevalence of thrombosis, and recent developments in the pharmaceutical industry. Geographically, the global antithrombotic/anticoagulant drugs market has been segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to hold a high share of the global antithrombotic/anticoagulant drugs market during the forecast period, owing to development of new drugs and increasing prevalence of cardiovascular and blood-related diseases in the region. The market in Asia Pacific is expected to register high CAGR during the forecast period owing to presence of high population based countries such as India and China in the region. Both producers and sellers of antithrombotic and anticoagulant drugs will see growth in the region. Most of the times, these drugs are readily available in the market. However, not a single drug is sufficiently effective in tackling the disease and is without any side-effects. As a result, search for newer and better versions of antithrombotic and anticoagulant drugs without side-effects is being carried out by different players. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1308 Key players operating in the global antithrombotic/anticoagulant drugs market are Bayer AG, Novartis AG, GlaxoSmithKline plc, Bristol Myers Squibb Company, Sanofi, Boehringer Ingelheim GmbH, Genentech, Inc., AstraZeneca plc, Eli Lilly & Company, and Pfizer, Inc. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www.transparencymarketresearch.com/ (Added: Tue Jan 01 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Global Neurosurgery Surgical Power Tools Market Recent Industry Trends - Technological advancements in electrical neurosurgical drills power tools over the years have resulted in reduced post-operative pain and discomforts, which is expected to contribute to the growth of the global Neurosurgery Surgical Power Tools. Technological advancements, coupled with increasing number of skull-based surgeries and craniotomy procedures are projected to increase the adoption of Neurosurgery Surgical Power Tools globally. According to the latest research by the company, the global Neurosurgery Surgical Power Tools market is expected to account for over US$ 123.2 Mn, in terms of value, by 2028 end. The report further projects a steady growth rate for the neurosurgery surgical power tools market through 2028. The neurosurgery surgical power tools efficiently reduce the number of activities during a surgery due to their light weight and adjustable speed. They reach the smallest regions of the brain and skull. Increasing prevalence of neurological disorders—brain injuries and cerebral disorders—presence of large patient pool, and advent of new neurosurgery surgical power tools are factors expected to drive the growth of the neurosurgery surgical power tools market during the forecast period. The companies operating in the market are adopting strategic approaches in order to increase their product reach in the global neurosurgery surgical power tools market. The need to make improvements in the surgeries to avoid mishaps, reduce post-operative pain and trauma is the prime factor expected to increase the adoption of neurosurgery surgical power tools. Increasing product approvals of neurosurgery surgical power tools and number of neurosurgeons opting for modern devices are also expected to boost the growth of the neurosurgery surgical power tools market. Neurosurgery surgical power tools are available with attachments that help in deciding the least damaging routes. The new neurosurgery surgical power tools have replaced the older versions with reduced thermal warming and integrated motors, which are much more reliable. Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8159 Neurosurgery surgical power tools market is consolidated in nature with three players accounting for majority of the global revenues. The companies operating in the market are focusing on launching new electric Electrical Neurosurgical Drills to further increase precision during surgeries. The manufacturers are conducting product awareness and training programs for surgeons and practitioners to boost end user product penetration and gain maximum revenue share in the global neurosurgery surgical power tools market. According to the Neuroscience Institute, around 3,600 neurosurgeries are performed annually. Experts note that device operating risks associated with neurosurgeries are projected to hamper the growth of the neurosurgery surgical power tools market. This factor is expected to negatively impact the growth of the global neurosurgery surgical power tools market over the forecast period. According to the report, the electrical neurosurgical drills segment accounted for over 58% revenue share in the global neurosurgery surgical power tools market in 2017. Furthermore, the pneumatic neurosurgical drills segment accounted for 42.1% revenue share in neurosurgery surgical power tools market. Moreover, the popularity of electrical neurosurgical drills is also increasing, which is expected to limit the growth of other segment of neurosurgery surgical power tools in the near future. Electrical neurosurgical drills in the Asia Pacific market is expected to be the lucrative segment over the forecast period in the global neurosurgery surgical power tools market. Request to View TOC @ https://www.futuremarketinsights.com/reports/neurosurgery-surgical-power-tools-market#tbl-content The company has segmented the global neurosurgery surgical power tools market into electrical neurosurgical drills, which offer high speed and torque, and pneumatic neurosurgical drills. In terms of revenue, the electrical neurosurgical drills segment in the neurosurgery surgical power tools market is expected to hold significant revenue share over the forecast period. The company’s report tracks some of the key companies operating in neurosurgery surgical power tools market, including Stryker Corporation, ADEOR MEDICAL AG, AYGUN CO., INC, B. Braun Melsungen AG, De Soutter Medical, Johnson & Johnson Services, Inc., ACRA-CUT Inc., KARL STORZ SE & Co. KG, and Medtronic plc., among others. (Added: Tue Jan 01 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Colorectal Cancer Market Business Opportunities and Future Analysis - The World Cancer Research Fund International establishes that colorectal cancer is the third most common cancer in the world and in 2012 alone, an estimated 1.4 mn new cases were diagnosed. Of these, 54% cases were reported in developed countries. This growing incidence is the primary factor fueling the global colorectal cancer market, especially in the field of diagnostics, therapeutics, and treatment. Read Report Overview: https://www.transparencymarketresearch.com/colorectal-cancer-market.html While the number of new colorectal cancer cases has been increasing year by year, the death rate from the same has been on a decline among women as well as men. The American Cancer Society pegs increased awareness among people and the development of new screening methods and more effective treatments as the most likely reasons for this. With a greater sense of awareness about colorectal cancer comes growing willingness toward early screening and diagnosis. This has had a positive impact on the overall colorectal cancer market. The report is a comprehensive database of information pertaining to the drivers, restraints, and opportunities defining the global colorectal cancer market. A detailed analysis of the current market dynamics, the latest innovations, business strategies of leading players, and recent events in the industry has been provided in the report for the period 2016 to 2024. The global colorectal cancer market is fueled by a number of factors, the primary one being high incidence of this disorder across emerging as well as developed regions. Apart from this, a massive aging population, the introduction of new and improved therapies and drugs, the rising uptake of higher-priced branded therapies, and several initiatives by governments and private organizations around the world to improve the level of awareness among patients and develop more efficacious therapeutics. A high unmet need in several emerging economies and a lack of adjuvant and neoadjuvant pipeline agents to treat high-risk patients with resectable colorectal cancer represents a lucrative avenue for players in this market. In contrast, however, factors such as the reluctance toward colorectal cancer medications on the part of patients and a certain lack of awareness in many parts of the world will pose a threat to the growth of the overall market. Geographically segmenting the global colorectal cancer market, the report covers four main segments: Asia Pacific, North America, Europe, and Rest of the World. North America is a key region in the market and accounts for a considerable share in terms of demand and revenue. This market is fueled by a number of factors, the primary one being greater prevalence of colorectal cancer. Based on estimates by the American Cancer Society, in 2017, 39,910 new rectal cancer cases and 95,520 new colon cancer cases will be reported in the U.S. In addition, an approximate 50,260 deaths resulting from colorectal cancer will be report this year. The North America colorectal cancer market is also driven by improved awareness about early detection, diagnosis, and screening, greater investments in research and development, the presence of leading drug and therapeutic companies, sophisticated healthcare infrastructure, and favorable reimbursement policies. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=107 Developing countries are fast emerging as major markets for colorectal cancer thanks to improving healthcare facilities and rising expenditure of preventive healthcare. Asia Pacific, as a result, is poised for strong growth in the coming years, with China and India making rapid progress. F. Hoffmann-La Roche Ltd., Merck KGaA, Bayer HealthCare Pharmaceuticals, Boehringer Ingelheim, Taiho Pharmaceutical, Eli Lilly and Company, and Pfizer, Inc. are presently the most promising companies operating in the global colorectal cancer market. The nature of the vendor landscape is immensely competitive with multinational companies establishing a strong hold over the rest. These players have been focused on devising successful strategies, such as competent marketing, expansion of geographical reach, prudent pricing, high investment in R&D, and offering clinical laboratory services. Product innovation is also viewed as one of the major growth strategies adopted by companies to gain a stronger foothold in the colorectal cancer market. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www.transparencymarketresearch.com/ (Added: Tue Jan 01 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Infant Incubator Market Growth Analysis By Top Major Players - Infant incubator is a device that is used to provide a controlled environment with the essential levels of warmth, humidity, and oxygen required by a newborn. The incubator unit is composed of a soft mattress, which is covered by a plastic cover, and is usually in the form of a trolley. It protects the infant from dust, noise, infection, and excess handling, providing a clean environment. In the incubator chamber, a temperature sensor adjusts the heat and maintains constant temperature for the infant. Furthermore, there is a humidification system and electric heating system in the incubator chamber to maintain humidity and to circulate humid air. These devices are essential to regulate the temperature for preterm infants as their normal metabolic rate is lower, leading to reduced heat production. Read Report Overview: https://www.transparencymarketresearch.com/infant-incubator-market.html The market for infant incubators is anticipated to grow owing to its various advantages enabling the well-being of newborns. The advent of infant incubators has enhanced the survival rate of preterm infants and has reduced the neonatal hypothermia. This factor contributes to the growth of the infant incubators market. In addition, the growing rate of preterm birth is likely to propel the growth of the market. According to the WHO, the number of premature child births is more than 15 million every year and is anticipated to increase over the years. However, high cost of these devices, availability of alternate modes such as infant warmers, and inadequacy of these devices in the developing regions are expected to restraint the market growth. In addition, the incubators limit the infant’s access to medical care, which might have a negative impact on the growth of the infant incubator market. Infant incubators can be classified as closed care infant warming devices. The global infant incubator market can be classified on the basis of product, end-user, and geography. On the basis of product, the market can be segmented into transport incubator and neonatal intensive care unit (NICU) incubator. The NICU incubators are anticipated to record a strong growth in the market. On the basis of end-user, the market can be segmented into pediatric hospitals, birthing centers, and neonatal intensive care units. Geographically, the global infant incubator market is distributed over North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is anticipated to record a high market share of the market during the forecast period. This can be attributed to the growing number of premature term babies and well-developed health care infrastructure. Europe is anticipated to be the second leading region in the infant incubator market. It is observed that the number of premature child births in Italy is more than 7% and is anticipated to increase over the years, contributing to the growth of the Europe market. However, the sluggish economic environment might negatively impact the growth of the market. According to the WHO, India and China are the leading countries in terms of number of premature child birth. The Asia Pacific market is expected to record a robust CAGR during the forecast period. This growth can be attributed to the significant contribution from the emerging countries such as China and India. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20393 The major players operating in the infant incubator market include GE Healthcare, Atom Medical Corporation, Natus Medical Incorporated, Cobams srl, AVI Healthcare Private Limited, Gammer International, Fanem Ltd, Ningbo David Medical Device Co., Ltd, Novos Medical Systems, and Ardo. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www.transparencymarketresearch.com/ (Added: Tue Jan 01 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Cushing’s syndrome Market to Experience Significant Growth during the Forecast Period 2017 to 2025 - Cushing’s syndrome is the collection of symptoms caused due to the high level of hormones called cortisol. Also known as hypercortisolism, the syndrome is often caused due to side effects of corticosteroid treatment. Corticosteroids are often used for treatment of inflammation and autoimmune conditions. Cushing’s syndrome can be of two types, iatrogenic Cushing’s syndrome and endogenous Cushing’s syndrome. Common symptoms of the syndrome include weight gain, fat tissue deposits around midsection and back, purple stretch marks, thinning skin which can be easily bruised, acne etc. Read Report Overview: https://www.transparencymarketresearch.com/cushings-syndrome-market.html The global Cushing’s syndrome market is expect to expand at a robust CAGR during the forecast period. Cushing’s syndrome is a rare disease and according to UCLA Health, the syndrome affects 10 to 15 people per million each year. Increasing prevalence of the disease is one of the important factors projected to drive the global Cushing’s syndrome market through 2025. Surge in prevalence of chronic diseases leading to increase in usage of corticosteroids is another factor likely to drive the market during the forecast period. The launch of novel drugs such as steroidogenesis inhibitors for treatment of Cushing’s syndrome is the key factor projected to propel the growth of the global Cushing’s syndrome market during the forecast period. Furthermore, unhealthy lifestyle, increase in geriatric population, and steroid abuse are factors attributed to the growth of the market. Difficulties in diagnosis, sparsely populated pipeline products, strict regulations etc are factors restraining the growth of the global Cushing’s syndrome market. The global Cushing’s syndrome market can be segmented into type, treatment, end users, and geographical expansion. On the basis of disease type, the market can be divided into iatrogenic Cushing’s syndrome and endogenous Cushing’s syndrome. On the basis of treatment, the market is divided into surgery, radiation therapy, drugs and others. The drugs segment is further divided into drug types such as Ketoconazole, Etomidate, Pasireotide, Aminoglutethimide and others. The drug segment is expected to hold a significant share during the forecast period due to factors such as effectiveness of drugs, their noninvasive nature, and fewer side effects than radiation therapies. The global Cushing’s syndrome market, on the basis of end users is segmented into hospitals, clinics, home care settings and others. Geographically the Cushing’s syndrome market is divided into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the market with the largest share in the global Cushing’s syndrome market. Increase in prevalence of obesity in young adults and children in the region leading to Cushing’s syndrome is one of the major factors driving the growth of the market in the region. Furthermore, advanced technology, rise in awareness among people about diagnosis of the disease, high healthcare expenditure etc. are some of the factors attributed to the growth of the North America Cushing’s syndrome market. Europe is also anticipated to hold a significant share of the global market, after North America. The Asia Pacific market is anticipated to register a faster growth rate during the forecast period. Asia Pacific is the most lucrative market due to growing geriatric population, adoption of healthcare solutions for better standard of life, rise in awareness about healthcare, prevalence of lifestyle related diseases etc. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30617 To maintain a significant position in the market, key players in the global Cushing’s syndrome market are operating strategies such as mergers and acquisitions, cost effective and efficient drugs, collaborative partnerships etc. Some of the prominent players operating in the Cushing’s syndrome market are Novartis Pharmaceuticals Corporation, Corcept Therapeutics, HRA Pharma and others. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www.transparencymarketresearch.com/ (Added: Mon Dec 31 2018 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Glycated Albumin Market By Geography, Trends And Growth - Glycated albumin is glucose bonded to an albumin molecule. Protein molecule i.e. albumin is present in the blood, major body organs, and body fluids. Function of albumin is to maintain shape of the cell and distribute hormones and nutrients. The amount of albumin decreases in the body when blood glucose levels are low, whereas increases when blood glucose levels are high. Glycated albumin is measured during initiation of diabetes therapies to determine medication dose for treatment of diabetes. According to a study conducted by American Association for Clinical Study, in 2011, glycated albumin is described as a novel biomarker for the detection and management of diabetes. Treatment of diabetes requires glycemic control. There are various measurements used to provide indicators, which include glycated hemoglobin (HbA1c), 1, 5-anhydroglucitol (1,5AG), and glycated albumin. Glycated hemoglobin (HbA1c) indicates the glycemic level during the first three months of diabetes incidence. This measurement is useful for the confirmation of short-term therapeutic efficacy during initiation of the treatment for diabetes. Increasing number of approvals of novel glycated albumin products in the market is expected to fuel the glycated albumin market growth in the near future In 2015, Asahi Kasei Pharma Corporation received CE Marking for its new Lucica Glycated Albumin-L, an in vitro diagnostic assay kit, for glycated albumin (GA-L) in Europe. Lucica Glycated Albumin-L is used for the quantitative measurement of glycated albumin in human serum on compatible clinical chemistry analyzers. In 2015, Lucica Glycated Albumin-L received approval in Taiwan, in 2013 it received approval in Indonesia, and Korea. In 2011, Diazyme Laboratories, Enzymatic glycated serum protein (GSP, Glycated Albumin) Assay Kit received approved by the U.S. Food and Drug Administration (FDA). Enzymatic glycated serum protein (GSP, Glycated Albumin) assay is two part liquid stable reagent, which can be used with various types of automated clinical chemistry analyzers. This product provides additional diagnostic values to clinical practices in diabetes management and screening. Thus, increasing approval of novel glycated albumin kits launched by key players in the market is expected to create a lucrative environment for the global glycated albumin market growth. The global glycated albumin market value was US$ XX Mn in 2017, and is expected to witness a CAGR of XX% over the forecast period (2018 – 2026). Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/1957 Increasing prevalence of diabetes is expected to fuel the glycated albumin market growth According to the International Diabetes Federation (IDF), the global diabetic population in 2015 was around 415 million and is expected to reach 642 million by 2040. Thus, rising prevalence of diabetes is expected to increase the demand for glycated albumin for its diagnosis, which in turn is expected to fuel the global glycated albumin assay market growth over the forecast period. North America is expected to hold a dominant position in the global glycated albumin kits market due to high prevalence of diabetes in region. For instance, according to data published by American Diabetes Association in 2015, around 1.25 million children and adults in the U.S. were suffering from type 1 diabetes and around 84.1 million people aged 18 years and above had prediabetes. Asia Pacific glycated albumin market is expected to show significant growth owing to increasing number of approvals for novel glycated albumin kits in the region. For instance, in 2015, Lucica Glycated Albumin-L by Asahi Kasei Pharma Corporation received approval in Taiwan. Company also received approval for its Lucica Glycated Albumin-L in Indonesia and Korea. This report provides in-depth analysis of glycated albumin market and provides market size (US$ Million) and cumulative annual growth rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players It profiles leading players in the global glycated albumin market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans Key companies covered as a part of this study include Lifespan Biosciences, Biomatik Corporation, Abbexa Ltd., G Biosciences, DRG International, Inc., Amsbio LLC, Signalway Antibody LLC, United States Biological, Diazyme Laboratories, Abnova Corporation, Maccura Biotechnology Co. Ltd., Exocell Inc., Biorbyt Ltd., and Epinex Diagnostics Inc. Click To Reading More On Glycated Albumin Market About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr.Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email:sales@coherentmarketinsights.com Visit our news Website: https://www.coherentwire.com (Added: Mon Dec 31 2018 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Fluoroscopy Market is expected to reach USD 2329.44 Million by 2023-Market Data Forecast - Recent Developments GE Healthcare is a multinational company; the company is a manufacturer and distributor of diagnostic imaging systems and radiopharmaceuticals for imaging modalities that are being used in medical imagining procedures. GE healthcare introduced anesthesia delivery to help clinicians worldwide to deliver tailored therapy to a broad range of patients; it is also customized as for the need of patients. GE acquired many companies so far as to strengthen the growth of the organization; one of the acquisitions is it acquired purify which conducts research and development activities on bioprocessing technologies. To know more read: https://www.marketdataforecast.com/market-reports/fluoroscopy-market-2066/ Market Segmentation Market Data Forecast published a report named Global Fluoroscopy Market it is currently valued USD 1990 Million in 2018 and it is expected to reach USD 2329.4 Million by 2023 at CAGR of 3.2% The report is segmented by Application · Biopsy · Cardiovascular Medications · Orthopedic Surgeries · Other Applications End User · Clinics · Hospitals · Diagnostics Centre The Cardiovascular medications segment is expected to overwhelm the worldwide fluoroscopy market over alternate sections because of a huge number of uses. Geographical Segmentation: Based on geography, the market is analyzed under North America, Europe, Asia-Pacific, Latin America, and Middle-East & Africa. North America is the largest shareholder of the market. Asia stands next to the region because a case of geriatric population is growing rapidly. Key market players in the market are - GE Healthcare., Orthoscan Inc., Hologic Inc., Shimadzu Corporation, Siemens Medical Solutions, View a sample and decide: https://www.marketdataforecast.com/market-reports/fluoroscopy-market-2066/request-sample The scope of the report: The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along with this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated. The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity. What else? Apart from the syndicated report, our in-house team has expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions. Contact Info: Name: Mr. Abhishek Shukla Email: abhishek@marketdataforecast.com Organization: MarketDataForecast™ Address: 2nd Floor, Above ICICI Bank Film Nagar Branch, B 44, Rd no 3, Journalist Colony, Hyderabad, Telangana 500033, India. Phone: +1-888-702-9626 (Added: Mon Dec 31 2018 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Prothrombin Complex Concentrates Market - A new study by the company titled 'Prothrombin Complex Concentrates Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018–2028', has listed out the key points being considered by the companies operating in the prothrombin complex concentrates market to emerge and stay sustainably profitable in the long run. The North America prothrombin complex concentrates market is projected to expand at a CAGR of 3.5% over the forecast period. North America and Western Europe are expected to be dominant markets for prothrombin complex concentrates, as most of the manufacturing facilities of prothrombin complex concentrates are located in these regions. However, the increasing demand for optimized & sustainable healthcare in countries of Asia Pacific, such as China and India, and of Middle-East is expected to fuel the growth of the prothrombin complex concentrates market. The report finds the players operating in the market are laying emphasis on improving treatment options for patients with hemophilia B. Treatment with prothrombin complex concentrates is an economical option for warfarin reversal. It is has been observed that the treatment with prothrombin complex concentrates is the most economical option as it minimizes the hospital stay and laboratory costs. Direct healthcare costs including drug and hospital costs in Europe are approximately US$ 400,000 for prothrombin complex concentrates, whereas for warfarin withdrawal therapy, it was approximated US$ 1,200,000. Manufacturers tend to depend on plasma as a primary precursor to manufacture prothrombin complex concentrates, and in the past, they relied on third-party sources for plasma. Manufacturers are now opening their own plasma collection banks to reduce dependence on third-party sources. This trend has been observed to have grown since 2013. The key players operating in the market, such as CSL Behring & Shire, have scaled up their focus on depending on their own sources for plasma. Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7032 Compound pharmacies, retail pharmacies, and hospital pharmacies distributing prothrombin complex concentrates are the primary point of contact for patients experiencing hemophilia B and other disorders. The hospital pharmacies segment in the prothrombin complex concentrates market accounted for over 40% revenue share in 2017. The growing demand for cost-effective diagnostic options is also expected to propel the growth of the global prothrombin complex concentrates market over the forecast period. The manufacturers of prothrombin complex concentrates are particularly focusing on acquisitions, collaborations, and opening plasma banks, where joint collaboration with various organizations is the prime activity to spread awareness regarding the efficiency of prothrombin complex concentrates. The growing geriatric population & unmet hemophilia therapeutic needs are also expected to be important factors fueling the growth of the prothrombin complex concentrates market over the forecast period. The worldwide incidence of hemophilia is not well known and it is estimated that 75% of people with hemophilia receive inadequate treatment or have no access to the treatment. The growth in the global population over 65 years of age is expected to be the high impact driver for the growth of the market. As per the U.S. Census Board, around 13% of the U.S. population is above 65 years old and this figure is estimated to touch 20 % by the end of 2030. Request to View TOC @ https://www.futuremarketinsights.com/reports/prothrombin-complex-concentrate-market#tbl-content Development of prothrombin complex concentrates and commercial production are highly intricate and complex. Prothrombin complex concentrates are prepared from pooled plasma. They pose a theoretical risk of transmitting infectious agents, which might survive the extraction and attenuation steps during the manufacturing process. There is a lack of substantial clinical evidence on contraindications and exclusion criteria, which is expected to hinder the growth of the prothrombin complex concentrates market over the forecast period. Examples of some of the key participants operating in the prothrombin complex concentrates market analyzed in this report are Shire, Octapharma AG, Nihon Pharmaceutical Co Ltd, Sanquin Blood Supply Foundation, CSL Behring GmbH, Kedrion Biopharma Inc, and Grifols, S.A (Added: Mon Dec 31 2018 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Disposable Blood Bags Market Regional Insights, Trends And Opportunities - In recent times, disposable plastic blood bags has replaced the usage of glass bottles due to problems associated with use of glass bottles including inadequate sterility, leading to blood contamination, and the presence of air bubbles resulted to severe complications during blood transfusion. Disposable plastic blood bags also help in the separation of blood components such as plasma, platelets, and cryoprecipitate, which are used to treat a range of blood disorders. The global disposable blood bags market size was valued at US$ 230.1 million in 2017, and is expected to witness a CAGR of 12.1% over the forecast period (2018 – 2026). Rising prevalence of diseases such as cancer and various blood related disorder (anemia, hemophilia, and sickle cell disease) is increasing demand for blood transfusion, which eventually drives growth of the disposable blood bags market. For instance, according to Red Cross Blood Organization facts of 2017 about blood needs, sickle cell disease affects 90,000 to 100,000 people in the U.S. and approximately 1,000 babies are born with the disease each year. Sickle cell patients often require blood transfusions throughout their lives. Increasing number of cancer incidences worldwide is also a major factor driving the disposable blood bags market’s growth. For instance, according to American Cancer Society, 2018, 1,735,350 new cancer cases and 609,640 cancer deaths are projected to occur in the U.S. by the end of 2018. Majority of these patients will need blood, sometimes daily, during chemotherapy treatment. Furthermore, according to the New York Blood Center, approximately 4.5 million Americans receive blood transfusions each year and 40,000 pints are transfused each day in the country, to save the lives of cancer patients, burn, accident, and trauma victims, mothers delivering babies, newborn babies, transplant patients, surgery patients and others in need. Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2170 Disposable Blood Bags Market Restraints Though the demand for blood transfusion is huge worldwide, there is a shortfall in blood supplies in low-income countries due to lack of a robust infrastructure for blood collection, distribution, and storage. In most of the emerging economies, there is no national blood service as a result organizations are struggling to provide blood to meet the needs of the population. Moreover, the medical infrastructure is also poor in these countries. Patients, in need of blood transfusion, are often located at great distances from hospitals and clinics, pushing up mortality rates. Production of disposable blood bags is stacked due to the presence of numerous stringent standards and regulations starting from manufacturing to marking for disposable blood bags. Disposable Blood Bags Market - Regional Insights On the basis of region, the global disposable blood bags market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. In 2026, North America is expected to hold the leading position in the global disposable blood bags market, owing to well-established medical and healthcare infrastructure providing timely blood transfusion services. Growing awareness among people for blood donation is also a major factor driving growth of the disposable blood bags market. According to the Red Cross Blood Organization blood supply statistics of 2017, an estimated 6.8 million people in the U.S. donate blood every year. Asia Pacific disposable blood bags market is expected to grow at the highest rate due to high demand for blood collection bags in the region. Growing healthcare facilities will act as a driver for growth of medical sector in countries such as India. Continuous developments and rising demand for better blood collection technology in the region is expected to boost the disposable blood bags market in the near future. Disposable Blood Bags Market - Competitive Landscape Key players operating in the global disposable blood bags market include AdvacarePharma, Fresenius Kabi, Grifols, HLL Lifecare, Haemonetics Corporation, Macopharma, Neomedic, Poly Medicure, SURU International, Span Healthcare, and TERUMO PENPOL. Use of biosafety materials in the manufacturing of blood bags and favorable support from government authorities is expected to create huge growth opportunities for disposable blood bag manufacturers. Click To Reading More On Disposable Blood Bags Market About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr.Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email:sales@coherentmarketinsights.com Visit our news Website: https://www.coherentwire.com (Added: Mon Dec 31 2018 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Spinal Cord Stimulation (SCS) Market is expected to reach USD 2,827.4 Million by 2023 - Recent Developments Medtronic is a medical device company; it is one among the world’s largest medical equipment development companies. FDA approved the company’s new synchronized II myPTM, which assists the patients to monitor their pain and can set doses based on the pain. It is known as Medtronic pump, is indicated for patients with chronic pain. Medtronic had launched beacon heart failure management service, designed to monitor data from cardiac pacing devices to improve early interventions before heart failure events. Medtronic’s acquisition of Mazor strengthens Medtronic’s position as a global leader in enabling technologies for heart surgeries, and drives Mazor Robotics; vision to bring its core technology to the forefront of the global market To know more read: https://www.marketdataforecast.com/market-reports/spinal-cord-stimulation-market-1306/ Market Segmentation Market Data Forecast published a report named Global SpinalCord Stimulation Market is currently valued USD 1871.6 million in 2018 and it is expected to reach USD 2827.4 million by 2023 at a CAGR of 8.6%. The report is segmented by Application · Degenerative Disk Disease (DDD) · Failed Back Syndrome (FBS) · Unsuccessful Disk Surgery · Complex Regional Pain Syndrome (CRPS) · Multiple Back Operations · Lumbar adhesive Arachnoiditis Product type · Non- Rechargeable · Rechargeable Geographical Segmentation: Based on Geography, the Spinal Cord Stimulation market is analyzed under various regions namely North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America has the highest share in the market followed by Europe and Asia-Pacific due to the presence of top manufacturers in the region. Asia-Pacific is accounted to have the highest CAGR over the forecast period owing to increasing prevalence in pain. Key market players in the market are - Boston Medtronic Nevro Jude Medical Great batch Stimwave View a sample and decide: https://www.marketdataforecast.com/market-reports/spinal-cord-stimulation-market-1306/request-sample The scope of the report: The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along with this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated. The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook on the market along with recommendations from industry experts on the opportunities for investment activity. What else? Apart from the syndicated report, our in-house team has expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions. Contact Info: Name: Mr. Abhishek Shukla Email: abhishek@marketdataforecast.com Organization: MarketDataForecast™ Address: 2nd Floor, Above ICICI Bank Film Nagar Branch, B 44, Rd no 3, Journalist Colony, Hyderabad, Telangana 500033, India. Phone: +1-888-702-9626 (Added: Mon Dec 31 2018 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Global Aquatic Vaccine Industry, 2018 Market Research Report - The ‘Global and Chinese Aquatic Vaccine Industry, 2013-2023 Market Research Report’ is a professional and in-depth study on the current state of the global Aquatic Vaccine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Aquatic Vaccine manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2013-2018 market shares for each company. Through the statistical analysis, the report depicts the global and Chinese total market of Aquatic Vaccine industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. The report then estimates 2018-2023 market development trends of Aquatic Vaccine industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out. In the end, the report makes some important proposals for a new project of Aquatic Vaccine Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2013-2023 global and Chinese Aquatic Vaccine industry covering all important parameters. Any special requirements about this report, please let us know and we can provide custom report. View Detailed Report:- http://oneresearchreports.com/report/global-and-chinese-aquatic-vaccine-industry,-2018-market-research-report Global and Chinese Aquatic Vaccine Industry, 2018 Market Research Report Chapter One Introduction of Aquatic Vaccine Industry 1.1 Brief Introduction of Aquatic Vaccine 1.2 Development of Aquatic Vaccine Industry 1.3 Status of Aquatic Vaccine Industry Chapter Two Manufacturing Technology of Aquatic Vaccine 2.1 Development of Aquatic Vaccine Manufacturing Technology 2.2 Analysis of Aquatic Vaccine Manufacturing Technology 2.3 Trends of Aquatic Vaccine Manufacturing Technology Chapter Three Analysis of Global Key Manufacturers 3.1 Company A 3.1.1 Company Profile 3.1.2 Product Information 3.1.3 2013-2018 Production Information 3.1.4 Contact Information 3.2 Company B 3.2.1 Company Profile 3.2.2 Product Information 3.2.3 2013-2018 Production Information 3.2.4 Contact Information 3.3 Company C 3.2.1 Company Profile 3.3.2 Product Information 3.3.3 2013-2018 Production Information 3.3.4 Contact Information 3.4 Company D 3.4.1 Company Profile 3.4.2 Product Information 3.4.3 2013-2018 Production Information 3.4.4 Contact Information 3.5 Company E 3.5.1 Company Profile 3.5.2 Product Information 3.5.3 2013-2018 Production Information 3.5.4 Contact Information 3.6 Company F 3.6.1 Company Profile 3.6.2 Product Information 3.5.3 2013-2018 Production Information 3.6.4 Contact Information 3.7 Company G 3.7.1 Company Profile 3.7.2 Product Information 3.7.3 2013-2018 Production Information 3.7.4 Contact Information 3.8 Company H 3.8.1 Company Profile 3.8.2 Product Information 3.8.3 2013-2018 Production Information 3.8.4 Contact Information …… …… Chapter Four 2013-2018 Global and Chinese Market of Aquatic Vaccine 4.1 2013-2018 Global Capacity, Production and Production Value of Aquatic Vaccine Industry 4.2 2013-2018 Global Cost and Profit of Aquatic Vaccine Industry 4.3 Market Comparison of Global and Chinese Aquatic Vaccine Industry 4.4 2013-2018 Global and Chinese Supply and Consumption of Aquatic Vaccine 4.5 2013-2018 Chinese Import and Export of Aquatic Vaccine Chapter Five Market Status of Aquatic Vaccine Industry 5.1 Market Competition of Aquatic Vaccine Industry by Company 5.2 Market Competition of Aquatic Vaccine Industry by Country (USA, EU, Japan, Chinese etc.) 5.3 Market Analysis of Aquatic Vaccine Consumption by Application/Type Chapter Six 2018-2023 Market Forecast of Global and Chinese Aquatic Vaccine Industry 6.1 2018-2023 Global and Chinese Capacity, Production, and Production Value of Aquatic Vaccine 6.2 2018-2023 Aquatic Vaccine Industry Cost and Profit Estimation 6.3 2018-2023 Global and Chinese Market Share of Aquatic Vaccine 6.4 2018-2023 Global and Chinese Supply and Consumption of Aquatic Vaccine 6.5 2018-2023 Chinese Import and Export of Aquatic Vaccine Chapter Seven Analysis of Aquatic Vaccine Industry Chain 7.1 Industry Chain Structure 7.2 Upstream Raw Materials 7.3 Downstream Industry Chapter Eight Global and Chinese Economic Impact on Aquatic Vaccine Industry 8.1 Global and Chinese Macroeconomic Environment Analysis 8.1.1 Global Macroeconomic Analysis 8.1.2 Chinese Macroeconomic Analysis 8.2 Global and Chinese Macroeconomic Environment Development Trend 8.2.1 Global Macroeconomic Outlook 8.2.2 Chinese Macroeconomic Outlook 8.3 Effects to Aquatic Vaccine Industry Chapter Nine Market Dynamics of Aquatic Vaccine Industry 9.1 Aquatic Vaccine Industry News 9.2 Aquatic Vaccine Industry Development Challenges 9.3 Aquatic Vaccine Industry Development Opportunities Chapter Ten Proposals for New Project 10.1 Market Entry Strategies 10.2 Countermeasures of Economic Impact 10.3 Marketing Channels 10.4 Feasibility Studies of New Project Investment Chapter Eleven Research Conclusions of Global and Chinese Aquatic Vaccine Industry View Detailed Report:- http://oneresearchreports.com/report/global-and-chinese-aquatic-vaccine-industry,-2018-market-research-report If you have any special requirements, please let us know and we will offer you the report as you want. (Added: Mon Dec 31 2018 Hits: 2 Rating: 0.00 Votes: 0) Rate It

Pages: [<<] ... 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 ... [>>]